Clinical Trial Opportunity for Women With Ovarian Cancer

		HysterSisters > Hormone Jungle Articles
Clinical Trial Opportunity for Women With Ovarian Cancer

Clinical Trial Opportunity for Women With Ovarian Cancer

Date : 06-22-2005 - 09:45 AM - Readers : 2674

Printer Friendly Version

January 20, 2005

This is a Phase III clinical trial (research study) of OvaRex® MAb (oregovomab) for women who have been diagnosed with Stage III/Stage IV ovarian cancer. OvaRex is a monoclonal antibody that targets CA125, a marker found in the blood associated with ovarian cancer. OvaRex is designed to help each patient’s immune system recognize ovarian cancer cells and fight their disease.

In this study, OvaRex is being used at a time shortly after successful front line therapy when there is no standard treatment. This period of time is called “watchful waiting”, and currently there are no approved products to treat ovarian cancer at this stage.

Click Here for More Info

Printer Friendly Version

HysterSisters is girlfriends with - Girls Get Going

-- Checking In - Feel Great - Lose Weight
The HysterSisters January 'Checking In' eMagazine has been published and should be in your email inbox if you are a regi [More]...

-- HysterSisters News - A New Look - Did You Receive It?

-- Our favorite products! HysterSisters Store
   Swelly Belly Band - Favorite!
   HysterSisters Guide - Helpful Advice!
   Very Private Moisture Great!
   Chillow Cooling Device Relief!

What 100,000 Women Know About Hysterectomy

*FREE* - Order HysterSisters booklet for yourself and your doctor! Order now!

This free booklet is made possible through the generosity of our sponsors:

HysterSisters.com is a patient support website and does not intend to take the place of the relationship between patient and personal physician.

Medical Advisory Team

Peer Support Websites: IC-Network